(Q45333052)

13 December 2017

title

Prospective multicenter study of eligibility for antiviral therapy among 4,084 U.S. veterans with chronic hepatitis C virus infection (English)

1 reference

13 December 2017

0 references

1 reference

1 reference

1 reference

1 reference

Edmund J Bini

1

1 reference

13 December 2017

Norbert Bräu

2

1 reference

13 December 2017

Sue Currie

3

1 reference

13 December 2017

Hui Shen

4

1 reference

13 December 2017

Bhupinderjit S Anand

5

1 reference

13 December 2017

Ke-Qin Hu

6

1 reference

13 December 2017

Lennox Jeffers

7

1 reference

13 December 2017

Samuel B Ho

8

1 reference

13 December 2017

David Johnson

9

1 reference

13 December 2017

Warren N Schmidt

10

1 reference

13 December 2017

Paul King

11

1 reference

13 December 2017

Ramsey Cheung

12

1 reference

13 December 2017

Timothy R Morgan

13

1 reference

13 December 2017

Joseph Awad

14

1 reference

13 December 2017

Marcos Pedrosa

15

1 reference

13 December 2017

Kyong-Mi Chang

16

1 reference

13 December 2017

Ayse Aytaman

17

1 reference

13 December 2017

Franz Simon

18

1 reference

13 December 2017

Curt Hagedorn

19

1 reference

13 December 2017

Richard Moseley

20

1 reference

13 December 2017

Jawad Ahmad

21

1 reference

13 December 2017

Charles Mendenhall

22

1 reference

13 December 2017

Bradford Waters

23

1 reference

13 December 2017

Doris Strader

24

1 reference

13 December 2017

Anna W Sasaki

25

1 reference

13 December 2017

Stephen Rossi

26

1 reference

13 December 2017

Teresa L Wright

27

1 reference

13 December 2017

language of work or name

English

0 references

publication date

1 August 2005

1 reference

The American Journal of Gastroenterology

13 December 2017

published in

1 reference

13 December 2017

volume

100

1 reference

13 December 2017

issue

8

1 reference

13 December 2017

page(s)

1772-1779

1 reference

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

13 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41860.X

Prevalence of hepatitis C virus seropositivity among hospitalized US veterans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41860.X

Prevalence and risk factors for hepatitis C virus infection at an urban Veterans Administration medical center

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41860.X

Prevalence of hepatitis C and coinfection with HIV among United States veterans in the New York City metropolitan area

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41860.X

Risk factors for hepatitis C virus infection among patients receiving health care in a Department of Veterans Affairs hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41860.X

Elevated prevalence of hepatitis C infection in users of United States veterans medical centers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41860.X

Spectrum of disease in U.S. veteran patients with hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41860.X

Depression, anxiety, post-traumatic stress, and alcohol-related problems among veterans with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41860.X

Psychiatric disorders among veterans with hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41860.X

A descriptive evaluation of eligibility for therapy among veterans with chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41860.X

Limited success of HCV antiviral therapy in United States veterans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41860.X

Psychosocial factors are the most common contraindications for antiviral therapy at initial evaluation in veterans with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41860.X

The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41860.X

Projecting future complications of chronic hepatitis C in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41860.X

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41860.X

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41860.X

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41860.X

Surprisingly small effect of antiviral treatment in patients with hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41860.X

Psychiatric comorbidity among hepatitis C-positive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41860.X

Diagnosis, management, and treatment of hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41860.X

10.1111/J.1572-0241.2005.41860.X

21 January 2018

Identifiers

DOI

1 reference

13 December 2017

1 reference